Literature DB >> 11912182

Classification of common conserved sequences in mammalian intergenic regions.

Alexey S Kondrashov1, Svetlana A Shabalina.   

Abstract

Comparisons between orthologous intergenic regions of related genomes reveal numerous hits, i.e. pairs of relatively short highly similar sequences that evolved slowly, perhaps due to selective constraint. We analyzed and classified 2638 hits found within 100 pairs of complete, orthologous intergenic regions of human and murine genomes. We identified all common fragments of hits that align well with many other hits and constructed their classification. Our analysis revealed 20 abundant classes each containing 10 or more fragments. Fragments of the same class may perform the same function, e.g. bind a particular protein. Ten of the abundant classes apparently correspond to known functional consensuses, whereas others may represent novel conserved sites. Thus, large-scale comparative analysis of slowly evolving intergenic sequences can provide valuable insights into their function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11912182     DOI: 10.1093/hmg/11.6.669

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  34 in total

1.  Analysis of similarity within 142 pairs of orthologous intergenic regions of Caenorhabditis elegans and Caenorhabditis briggsae.

Authors:  Colleen T Webb; Svetlana A Shabalina; Aleksey Yu Ogurtsov; Alexey S Kondrashov
Journal:  Nucleic Acids Res       Date:  2002-03-01       Impact factor: 16.971

2.  Reevaluating human gene annotation: a second-generation analysis of chromosome 22.

Authors:  John E Collins; Melanie E Goward; Charlotte G Cole; Luc J Smink; Elizabeth J Huckle; Sarah Knowles; Jacqueline M Bye; David M Beare; Ian Dunham
Journal:  Genome Res       Date:  2003-01       Impact factor: 9.043

3.  Patterns in interspecies similarity correlate with nucleotide composition in mammalian 3'UTRs.

Authors:  Svetlana A Shabalina; Aleksey Y Ogurtsov; David J Lipman; Alexey S Kondrashov
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

4.  Haldane and the first estimates of the human mutation rate.

Authors:  Michael W Nachman
Journal:  J Genet       Date:  2004-12       Impact factor: 1.166

Review 5.  Economy, speed and size matter: evolutionary forces driving nuclear genome miniaturization and expansion.

Authors:  Thomas Cavalier-Smith
Journal:  Ann Bot       Date:  2005-01       Impact factor: 4.357

6.  "Genome design" model: evidence from conserved intronic sequence in human-mouse comparison.

Authors:  Alexander E Vinogradov
Journal:  Genome Res       Date:  2006-02-03       Impact factor: 9.043

7.  Continuing evolution of Burkholderia mallei through genome reduction and large-scale rearrangements.

Authors:  Liliana Losada; Catherine M Ronning; David DeShazer; Donald Woods; Natalie Fedorova; H Stanley Kim; Svetlana A Shabalina; Talima R Pearson; Lauren Brinkac; Patrick Tan; Tannistha Nandi; Jonathan Crabtree; Jonathan Badger; Steve Beckstrom-Sternberg; Muhammad Saqib; Steven E Schutzer; Paul Keim; William C Nierman
Journal:  Genome Biol Evol       Date:  2010-01-22       Impact factor: 3.416

8.  Optimization of duplex stability and terminal asymmetry for shRNA design.

Authors:  Olga V Matveeva; Yibin Kang; Alexey N Spiridonov; Pål Saetrom; Vladimir A Nemtsov; Aleksey Y Ogurtsov; Yury D Nechipurenko; Svetlana A Shabalina
Journal:  PLoS One       Date:  2010-04-20       Impact factor: 3.240

9.  Abundance of type I toxin-antitoxin systems in bacteria: searches for new candidates and discovery of novel families.

Authors:  Elizabeth M Fozo; Kira S Makarova; Svetlana A Shabalina; Natalya Yutin; Eugene V Koonin; Gisela Storz
Journal:  Nucleic Acids Res       Date:  2010-02-15       Impact factor: 16.971

10.  Evolution of alternative and constitutive regions of mammalian 5'UTRs.

Authors:  Alissa M Resch; Aleksey Y Ogurtsov; Igor B Rogozin; Svetlana A Shabalina; Eugene V Koonin
Journal:  BMC Genomics       Date:  2009-04-16       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.